Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mathematician Neil Chriss Has Calculated Success For These Three Stocks

Page 1 of 2

Neil Chriss, a highly reputed mathematician, has also found his way into hedge fund management, having founded Hutchin Hill Capital in 2007. He went into the hedge fund business after spending some time working on Wall Street and has since built a name for himself as a result of his success. His fund submitted its 13F filing with the U.S. Securities and Exchange Commission for the period of March 31 and the filing showed that the fund sported a public equity portfolio value of $3.61 billion, representing an increase of 24.8% over the last quarter of 2014, while Hutchin Hill Capital maintained $6.73 billion in assets under management. In Chriss’ first years in the hedge fund business, he has posted 12% in annualized gains, approximately six times the average returns registered by his peers. With his multi-strategy approach, he has attracted large sums of capital from investors big and small. Chriss chooses his stocks carefully, carrying out thorough analysis to establish their potential before moving to secure portions in them. In this article, we are looking at three of his new picks made during the first quarter, which are Albemarle Corporation (NYSE:ALB), Darden Restaurants, Inc. (NYSE:DRI), and Kohl’s Corporation (NYSE:KSS).


Let’s first take a step back and analyze how tracking hedge funds can help an everyday investor. Through our research we discovered that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith in large-cap stocks. In forward tests since August 2012 these top small-cap stocks beat the market by an impressive 83 percentage points, returning over 142% (read the details here). Hence a retail investor needs to isolate himself from the herd and take advantage of the best growth opportunities in the market by concentrating on small-cap stocks.

Neil Chriss
Neil Chriss
Hutchin Hill Capital

Chriss roped Albemarle Corporation (NYSE:ALB) into his fold during the first quarter of 2015. At the close of the quarter, the Wall Street expert held a total of 1.08 million shares of the specialty chemical company, with his holding having a market value of $57.17 million. The Baton Rouge, Louisiana-based company acquired Rockwood Holdings, Inc. earlier this year and realigned its global business units in an effort to strengthen its international operations. For the first quarter of 2015, the company posted earnings per share of $1.17, representing a 19% rise compared to the first quarter of 2014. The earnings per share figure handily surpassed Thomson Reuters consensus estimate of $0.71. Analysts forecast $3.89 in earnings per share for the current fiscal year, falling within the company’s own guidance of $3.65-$4.05 per share. 38 of the hedge funds that we track had positions in Albemarle Corporation (NYSE:ALB) at the end of the first quarter, with their holdings having an aggregate value of $595.33 million. Jeffrey Gates‘ Gates Capital Management and Ross Margolies’ Stelliam Investment Management are among the funds that had stakes in the stock.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!